Koers BioMerieux SA Xetra
Aandelen
EYW
FR0010096479
Medische apparatuur, benodigdheden & distributie
Omzet 2024 * | 3,9 mld. 4,24 mld. | Omzet 2025 * | 4,19 mld. 4,56 mld. | Marktkapitalisatie | 11,38 mld. 12,39 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 468 mln. 509 mln. | Nettowinst (verlies) 2025 * | 529 mln. 576 mln. | EV/omzet 2024 * | 2,85 x |
Nettoliquiditeiten 2024 * | 264 mln. 288 mln. | Nettoliquiditeiten 2025 * | 447 mln. 486 mln. | EV/omzet 2025 * | 2,61 x |
K/w-verhouding 2024 * |
24,9
x | K/w-verhouding 2025 * |
22
x | Werknemers | - |
Dividendrendement 2024 * |
0,9% | Dividendrendement 2025 * |
1,04% | Vrij verhandelbaar | 36,23% |
Recentste transcriptie over BioMerieux SA
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Pierre Boulud
CEO | Chief Executive Officer | 52 | 01-11-16 |
Chairman | 50 | 16-04-04 | |
Director of Finance/CFO | 47 | 01-03-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 74 | 15-09-06 | |
Director/Board Member | 63 | 01-01-05 | |
Chairman | 50 | 16-04-04 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,76% | 8,43 mld. | |
+6,71% | 5,77 mld. | |
+33,19% | 5,76 mld. | |
-10,28% | 4,1 mld. | |
+10,72% | 2,66 mld. | |
-62,03% | 2,66 mld. | |
-8,27% | 2,39 mld. | |
+17,08% | 2,02 mld. | |
-7,29% | 1,77 mld. |